Erythromycin
Levodopa
Virginia Commonwealth UniversitySmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Levodopa cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Doxycycline Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Phase 2 | CCC |
PANITUMUMAB Neurological Rehabilitation Hospital Rosenhügel | N/A | D |
Same molecule, other indications
Erythromycin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →